chr2-135135802-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012233.3(RAB3GAP1):​c.1793A>G​(p.Asn598Ser) variant causes a missense change. The variant allele was found at a frequency of 0.147 in 1,613,824 control chromosomes in the GnomAD database, including 24,629 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 2387 hom., cov: 32)
Exomes 𝑓: 0.15 ( 22242 hom. )

Consequence

RAB3GAP1
NM_012233.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 5.03

Publications

43 publications found
Variant links:
Genes affected
RAB3GAP1 (HGNC:17063): (RAB3 GTPase activating protein catalytic subunit 1) This gene encodes the catalytic subunit of a Rab GTPase activating protein. The encoded protein forms a heterodimer with a non-catalytic subunit to specifically regulate the activity of members of the Rab3 subfamily of small G proteins. This protein mediates the hydrolysis of GTP bound Rab3 to the GDP bound form. Mutations in this gene are associated with Warburg micro syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]
RAB3GAP1 Gene-Disease associations (from GenCC):
  • Warburg micro syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Warburg micro syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cataract-intellectual disability-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003854096).
BP6
Variant 2-135135802-A-G is Benign according to our data. Variant chr2-135135802-A-G is described in ClinVar as Benign. ClinVar VariationId is 130064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.369 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAB3GAP1NM_012233.3 linkc.1793A>G p.Asn598Ser missense_variant Exon 17 of 24 ENST00000264158.13 NP_036365.1 Q15042-1B9A6J2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAB3GAP1ENST00000264158.13 linkc.1793A>G p.Asn598Ser missense_variant Exon 17 of 24 1 NM_012233.3 ENSP00000264158.8 Q15042-1

Frequencies

GnomAD3 genomes
AF:
0.145
AC:
22013
AN:
152076
Hom.:
2384
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0371
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.400
Gnomad EAS
AF:
0.382
Gnomad SAS
AF:
0.294
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.147
Gnomad OTH
AF:
0.204
GnomAD2 exomes
AF:
0.204
AC:
51342
AN:
251228
AF XY:
0.211
show subpopulations
Gnomad AFR exome
AF:
0.0327
Gnomad AMR exome
AF:
0.249
Gnomad ASJ exome
AF:
0.397
Gnomad EAS exome
AF:
0.389
Gnomad FIN exome
AF:
0.144
Gnomad NFE exome
AF:
0.154
Gnomad OTH exome
AF:
0.237
GnomAD4 exome
AF:
0.147
AC:
214878
AN:
1461630
Hom.:
22242
Cov.:
33
AF XY:
0.154
AC XY:
112059
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.0359
AC:
1202
AN:
33474
American (AMR)
AF:
0.244
AC:
10892
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.392
AC:
10238
AN:
26132
East Asian (EAS)
AF:
0.404
AC:
16023
AN:
39696
South Asian (SAS)
AF:
0.287
AC:
24760
AN:
86252
European-Finnish (FIN)
AF:
0.148
AC:
7879
AN:
53414
Middle Eastern (MID)
AF:
0.345
AC:
1990
AN:
5766
European-Non Finnish (NFE)
AF:
0.118
AC:
130815
AN:
1111798
Other (OTH)
AF:
0.183
AC:
11079
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
10460
20921
31381
41842
52302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4518
9036
13554
18072
22590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.145
AC:
22033
AN:
152194
Hom.:
2387
Cov.:
32
AF XY:
0.151
AC XY:
11252
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0370
AC:
1539
AN:
41558
American (AMR)
AF:
0.229
AC:
3506
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.400
AC:
1388
AN:
3468
East Asian (EAS)
AF:
0.383
AC:
1975
AN:
5160
South Asian (SAS)
AF:
0.294
AC:
1421
AN:
4826
European-Finnish (FIN)
AF:
0.144
AC:
1526
AN:
10590
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.147
AC:
10004
AN:
67990
Other (OTH)
AF:
0.209
AC:
442
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
860
1720
2581
3441
4301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.166
Hom.:
8451
Bravo
AF:
0.144
TwinsUK
AF:
0.108
AC:
399
ALSPAC
AF:
0.111
AC:
427
ESP6500AA
AF:
0.0313
AC:
138
ESP6500EA
AF:
0.154
AC:
1324
ExAC
AF:
0.201
AC:
24339
Asia WGS
AF:
0.321
AC:
1117
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Warburg micro syndrome 1 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Martsolf syndrome 2 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.051
T;.;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.066
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.86
D;D;D
MetaRNN
Benign
0.0039
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.92
L;L;.
PhyloP100
5.0
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.60
N;N;N
REVEL
Benign
0.14
Sift
Benign
0.26
T;T;T
Sift4G
Benign
0.82
T;T;T
Polyphen
0.0010
B;.;.
Vest4
0.073
MPC
0.18
ClinPred
0.010
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.031
gMVP
0.084
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10445686; hg19: chr2-135893372; COSMIC: COSV51482881; COSMIC: COSV51482881; API